Cabaletta Bio, Inc. · NASDAQ:CABA
Cabaletta Bio, Inc. shareholders
As of Sep 30, 2026, 155 institutions reported holding Cabaletta Bio, Inc., 87.5% of its shares. Largest: Jennison Associates LLC, T. Rowe Price and Bain Capital Life Sciences Investors, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cabaletta Bio, Inc. | Change | Filed |
|---|---|---|---|---|
| Jennison Associates LLC | 25.1M | 11.7% | +5.11M | Nov 13, 2026 |
| T. Rowe Price | 23.5M | 10.9% | +197K | Nov 16, 2026 |
| Bain Capital Life Sciences Investors, LLC | 21.2M | 9.8% | +3.97M | Nov 16, 2026 |
| BlackRock | 14.4M | 6.7% | +3.63M | Nov 13, 2026 |
| Adage Capital Partners Gp, L.L.C. | 14.2M | 6.6% | +5M | Nov 16, 2026 |
| Vanguard | 10.6M | 4.9% | +787K | Nov 16, 2026 |
| State Street | 8.05M | 3.7% | +214K | Nov 12, 2026 |
| Woodline Partners LP | 5.2M | 2.4% | +1M | Nov 16, 2026 |
| Alyeska Investment Group, L.P. | 4.5M | 2.1% | new | Nov 16, 2026 |
| Cormorant Asset Management, LP | 4.5M | 2.1% | −500K | Nov 16, 2026 |